Nootropic Ingredients Guide 2026
Evidence-based breakdown of the most studied nootropic compounds available in the EU. Clinical doses, mechanisms of action, and which EU-compliant stacks contain each ingredient.
| Ingredient | Category | Clinical dose | Time to effect | Products |
|---|---|---|---|---|
| Lion's Mane | Mushroom | 500–1000mg/day (standardised fruiting body extract) | 4–8 weeks of consistent use | |
| Bacopa Monnieri | Herb | 300–450mg/day (standardised to 55% bacosides) | 6–12 weeks of consistent use | |
| Citicoline (CDP-Choline) | Cholinergic | 250–500mg/day | Acute effects within 1–2 hours; optimal at 4–6 weeks | |
| L-Theanine | Amino Acid | 100–200mg/day (often paired with caffeine at 1:2 ratio) | 30–60 minutes (acute) | |
| Rhodiola Rosea | Adaptogen | 200–600mg/day (standardised to 3% rosavins, 1% salidroside) | 1–2 weeks for baseline effects; acute anti-fatigue within hours | |
| Phosphatidylserine | Cholinergic | 100–300mg/day (soy-free sunflower-derived preferred) | 4–6 weeks for memory effects; cortisol reduction within 2 weeks | |
| Alpha-GPC | Cholinergic | 300–600mg/day | 1–2 hours (acute); optimal cognitive effects at 4 weeks | |
| Ashwagandha (KSM-66) | Adaptogen | 300–600mg/day (KSM-66 extract) | 2–4 weeks for anxiety/stress; 4–8 weeks for cognitive effects | |
| Huperzine A | Herb | 50–200mcg/day (note: micrograms, not milligrams) | 30–60 minutes (acute) | |
| L-Tyrosine (NALT) | Amino Acid | 500–2000mg/day (L-Tyrosine); 300–500mg as NALT | 30–60 minutes before a demanding cognitive task |
Lion's Mane
MushroomA 2009 double-blind, placebo-controlled trial (Mori et al.) found significant improvements in cognitive function scores in mild cognitive impairment subjects after 16 weeks of 3g/day. A 2020 study found measurable nerve regeneration effects at 500mg standardised extract. Evidence is strongest for long-term neuroprotection rather than acute effects.
Bacopa Monnieri
HerbA meta-analysis of 9 RCTs (Kongkeaw et al., 2014) found Bacopa significantly improved attention, cognitive processing, and working memory versus placebo. Effects are cumulative — most studies measure outcomes at 8–12 weeks. Best evidence is for memory consolidation rather than acute recall.
Citicoline (CDP-Choline)
CholinergicMultiple RCTs (Spiers et al., 1996; Secades & Lorenzo, 2006) show citicoline improves attention, working memory, and verbal memory in healthy adults and cognitive decline patients. It is one of the most bioavailable choline sources — studies show ~18% greater cognitive improvement compared to choline bitartrate.
L-Theanine
Amino AcidA 2008 RCT (Haskell et al.) found the L-theanine + caffeine combination significantly improved attention and alertness vs. either compound alone. Multiple studies confirm alpha wave induction within 45 minutes. It is one of the best-evidenced acute nootropics for calm focus without sedation.
Rhodiola Rosea
AdaptogenA 2009 RCT (Shevtsov et al.) found significant reductions in mental fatigue and improved cognitive function in night-shift physicians after single doses. A larger 2012 Swedish study confirmed sustained benefits for stress-induced burnout over 12 weeks. Strongest evidence for anti-fatigue and stress resilience.
Phosphatidylserine
CholinergicFDA allows a qualified health claim for PS and reduced risk of dementia. Multiple RCTs (Crook et al., 1991; Cenacchi et al., 1993) show improvements in memory, learning, and concentration in age-related cognitive decline. The 2010 soy-free sunflower-derived form shows equivalent bioavailability to the original bovine-cortex-derived PS used in older trials.
Alpha-GPC
CholinergicItalian multicenter trials (De Jesus Moreno, 2003) in Alzheimer's patients found Alpha-GPC improved memory scores more than placebo over 90 days. Sports studies (Bellar et al., 2015) confirm power output increases in athletes at 600mg. Of all choline sources, Alpha-GPC has the strongest acute cognitive data.
Ashwagandha (KSM-66)
AdaptogenA 2019 RCT (Choudhary et al.) found KSM-66 at 300mg twice daily significantly improved memory, attention, and information processing speed versus placebo over 8 weeks. A 2012 RCT showed 27.9% reduction in cortisol. KSM-66 has the most clinical trials of any ashwagandha extract (>24 gold-standard studies).
Huperzine A
HerbMultiple Chinese RCTs (Xu et al., 1995; Zhang et al., 2002) show Huperzine A significantly improved memory and learning in Alzheimer's patients and students. A meta-analysis of 20 studies confirms its efficacy for memory. Requires cycling (5 days on, 2 days off) due to long half-life and potential acetylcholine accumulation.
L-Tyrosine (NALT)
Amino AcidMilitary research (Neri et al., 1995; Deijen et al., 1999) shows tyrosine supplementation significantly reduced performance decrements from sleep deprivation and cold stress. A 2015 meta-analysis confirmed benefits specifically during multitasking and high-demand cognitive scenarios. Benefits are most pronounced under stress, not in rested baseline conditions.